Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Anders Raak"'
Autor:
Ragnhild Raak, Anders Raak
Publikováno v:
Headache: The Journal of Head and Face Pain. 43:1097-1101
Objective.—To study work attendance despite headache in 2 different workplaces and its economic impact. Background.—Literature on the economic impact of headache traditionally has focused on direct costs. Little is known concerning headache exper
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c524e639d651e25acf42503406276ee
https://doi.org/10.1046/j.1526-4610.2003.03212.x
https://doi.org/10.1046/j.1526-4610.2003.03212.x
Publikováno v:
Rehabilitation nursing : the official journal of the Association of Rehabilitation Nurses. 27(3)
A pain rehabilitation model that focused on emotions was implemented to influence catastrophizing by, and health-related quality of life (HRQL) for, persons with chronic low back pain. Twelve individuals, 7 men and 5 women (aged 33 to 57 years), all
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::854becdfb0cc7cd5f13b8040e58f6702
https://pubmed.ncbi.nlm.nih.gov/12004563
https://pubmed.ncbi.nlm.nih.gov/12004563
Autor:
Tommy Jäverfalk, Anders Raak, Valur Johannsson, Margareta Troein, Göran Almkvist, CarI-Lennart Gustafsson, Björn Tilling, Tommy Widelius, Lars R. Nilsson, Peter Hellman, Jan-Åke Åkesson, Bengt Olerud, Gun Sandahl
Publikováno v:
Headache: The Journal of Head and Face Pain. 27:372-374
SYNOPSIS The prophylactic anti-migraine effect of atenolol was compared to placebo in a multicentre study on 63 patients with classical and/or common migraine. The study design was double-blind cross-over and patients were given atenolol 100 mg o.d.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7a82c6a0af3c5862bcdcdac3d988503
https://doi.org/10.1111/j.1526-4610.1987.hed2707372.x
https://doi.org/10.1111/j.1526-4610.1987.hed2707372.x
Publikováno v:
Current medical research and opinion. 5(5)
A randomized, double-blind study was carried out in 24 patients with stable angina pectoris to compare the efficacy of nadolol, a new beta-adrenoceptor antagonist, and propranolol. After a period on placebo, 14 patients received nadolol once daily an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11643d2ebf936f0bd79158836442da27
https://pubmed.ncbi.nlm.nih.gov/26520
https://pubmed.ncbi.nlm.nih.gov/26520